Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting
Exicure (Nasdaq: XCUR) announced an additional adjournment of its Special Meeting of Stockholders, initially scheduled for August 15, 2024, and reconvened on August 19, 2024. The meeting has been adjourned again due to lack of quorum, with only 49.7% of outstanding shares represented at the reconvened meeting. The Special Meeting will be reconvened on August 20, 2024, at 9:00 a.m. Central Time, held virtually via live audio-only webcast.
The record date for voting eligibility remains July 26, 2024. Previously submitted proxies will be valid for the adjourned meeting unless revoked. Stockholders who haven't voted are encouraged to do so via the Internet at www.proxyvote.com or by phone at 1-800-690-6903.
Exicure (Nasdaq: XCUR) ha annunciato un ulteriore rinvio della sua Assemblea Straordinaria degli Azionisti, inizialmente programmata per il 15 agosto 2024 e riconvocata per il 19 agosto 2024. L'assemblea è stata nuovamente rinviata a causa della mancanza di quorum, con solo 49,7% delle azioni in circolazione rappresentate all'incontro riconvocato. L'Assemblea Straordinaria sarà riconvocata il 20 agosto 2024, alle 9:00 ora centrale, tenuta virtualmente tramite un webcast audio in diretta.
La data di registrazione per la validità del voto rimane 26 luglio 2024. Le deleghe già inviate rimarranno valide per l'assemblea rinviata, a meno che non siano revocate. Gli azionisti che non hanno votato sono incoraggiati a farlo via Internet su www.proxyvote.com o telefonicamente al numero 1-800-690-6903.
Exicure (Nasdaq: XCUR) anunció un nuevo aplazamiento de su Junta Especial de Accionistas, inicialmente programada para el 15 de agosto de 2024 y reprogramada para el 19 de agosto de 2024. La reunión ha sido aplazada nuevamente debido a la falta de quórum, con solo 49.7% de las acciones en circulación representadas en la reunión reprogramada. La Junta Especial será reprogramada para el 20 de agosto de 2024, a las 9:00 a.m. hora central, y se llevará a cabo virtualmente a través de un webcast de audio en vivo.
La fecha de corte para la elegibilidad del voto sigue siendo 26 de julio de 2024. Las representaciones presentadas anteriormente serán válidas para la reunión aplazada a menos que se revoquen. Se anima a los accionistas que no hayan votado a hacerlo a través de Internet en www.proxyvote.com o por teléfono al 1-800-690-6903.
Exicure (Nasdaq: XCUR)는 2024년 8월 15일로 예정된 주주 특별 회의가 2024년 8월 19일로 재소집되었음을 알리고, 다시 한 번 연기되었음을 발표했습니다. 연기된 회의에서 단 49.7%의 발행 주식만이 대표되어 퀘럼 부족으로 인해 회의가 다시 연기되었습니다. 특별 회의는 2024년 8월 20일 오전 9:00 중앙 시간에 가상으로 라이브 오디오 웹캐스트를 통해 재소집될 것입니다.
투표 자격을 위한 기준일은 2024년 7월 26일로 유지됩니다. 이전에 제출된 위임장은 취소되지 않는 한, 연기된 회의에서 유효합니다. 아직 투표하지 않은 주주들은 www.proxyvote.com를 통해 인터넷으로 투표하거나 전화 1-800-690-6903으로 해주실 것을 권장합니다.
Exicure (Nasdaq: XCUR) a annoncé un nouvel ajournement de son Assemblée Générale Extraordinaire des Actionnaires, initialement prévue pour le 15 août 2024 et reconvoquée le 19 août 2024. La réunion a de nouveau été ajournée en raison du manque de quorum, avec seulement 49,7 % des actions en circulation représentées lors de la réunion reconvoquée. L'Assemblée Générale Extraordinaire sera reconvoquée le 20 août 2024 à 9h00 heure centrale, et se tiendra virtuellement par le biais d'un webcast audio en direct.
La date d'enregistrement pour l'éligibilité au vote reste le 26 juillet 2024. Les procurations précédemment soumises resteront valides pour la réunion ajournée à moins d'être révoquées. Les actionnaires qui n'ont pas encore voté sont encouragés à le faire via Internet sur www.proxyvote.com ou par téléphone au 1-800-690-6903.
Exicure (Nasdaq: XCUR) hat eine weitere Verschiebung seiner außerordentlichen Hauptversammlung der Aktionäre angekündigt, die ursprünglich für den 15. August 2024 und erneut für den 19. August 2024 angesetzt war. Die Versammlung wurde erneut verschoben, da nicht genügend Aktionäre anwesend waren; nur 49,7% der ausstehenden Aktien waren bei der wieder einberufenen Versammlung vertreten. Die außerordentliche Hauptversammlung wird am 20. August 2024 um 9:00 Uhr Central Time wieder einberufen und findet virtuell über einen Live-Audio-Webcast statt.
Das Stichtagsdatum für die Wahlberechtigung bleibt der 26. Juli 2024. Bereits eingereichte Vollmachten sind für die verschobene Versammlung gültig, es sei denn, sie werden widerrufen. Aktionäre, die noch nicht abgestimmt haben, werden ermutigt, dies über das Internet unter www.proxyvote.com oder telefonisch unter 1-800-690-6903 zu tun.
- None.
- Failure to reach quorum for Special Meeting
- Low stockholder participation (49.7% of outstanding shares represented)
The presence, in person, by remote communication or by proxy, of the holders of a majority of the outstanding shares of stock entitled to vote constitutes a quorum. There was less than the required majority represented at the reconvened Special Meeting, so a quorum did not exist. At the time the Special Meeting was adjourned on August 19, 2024, proxies had been submitted by stockholders representing approximately
The Special Meeting will be reconvened again on August 20, 2024 at 9:00 a.m. Central Time and will continue to be held virtually and exclusively online via live audio-only webcast at www.virtualshareholdermeeting.com/XCUR2024SM.
The record date for determination of stockholders entitled to vote at the reconvened Special Meeting remains July 26, 2024.
Proxies previously submitted in respect of the Special Meeting will be voted at the adjourned Special Meeting unless properly revoked, and stockholders who have previously submitted a proxy or otherwise voted need not take any action.
Stockholders who have not yet voted are encouraged to vote as soon as possible via the Internet at www.proxyvote.com or by phone at 1-800-690-6903. You will be asked to provide the control number from your proxy card and follow the instructions.
If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you should have received these proxy materials and a voting instructions from that organization rather than from us. Simply follow the instructions to ensure that your vote is counted.
About Exicure
Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. For further information, see www.exicuretx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240819719284/en/
Josh Miller
847-673-1700
media@exicuretx.com
Source: Exicure, Inc.
FAQ
When is Exicure's (XCUR) reconvened Special Meeting of Stockholders?
What percentage of Exicure's (XCUR) outstanding shares were represented at the August 19, 2024 meeting?
What is the record date for Exicure's (XCUR) Special Meeting of Stockholders?
How can Exicure (XCUR) stockholders vote for the Special Meeting?
